@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix agrovoc: <http://aims.fao.org/aos/agrovoc/> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .

<https://lod.nal.usda.gov/naltv#marc001> rdfs:label "Field 001 in MARC Authority Format"@en .
nalt:10543_def
  a <https://lod.nal.usda.gov/naltv#Definition> ;
  rdf:value "Tipo de terapia biológica que usa sustancias para estimular o suprimir el sistema inmunitario, a fin de ayudar al cuerpo a luchar contra el cáncer, las infecciones y otras enfermedades. Algunos tipos de inmunoterapia solo se enfocan en ciertas células de dicho sistema, mientras que otras influyen en él de manera general. Entre algunos tipos se incluyen las citocinas, las vacunas, el bacilo de Calmette-Guerin (BCG) y algunos anticuerpos monoclonales."@es, "A type of biological therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases. Some types of immunotherapy only target certain cells of the immune system. Others affect the immune system in a general way. Types of immunotherapy include cytokines, vaccines, bacillus Calmette-Guerin (BCG), and some monoclonal antibodies."@en ;
  dc:source "National Cancer Institute" .

<https://lod.nal.usda.gov/nalt>
  a skos:ConceptScheme ;
  rdfs:label "NALT Full"@en .

<https://lod.nal.usda.gov/naltv#Topic>
  a owl:Class ;
  rdfs:label "Topic"@en .

nalt:10543
  a skos:Concept, <https://lod.nal.usda.gov/naltv#Topic> ;
  dc:created "2006-01-19"^^xsd:date ;
  dc:modified "2020-01-21"^^xsd:date ;
  skos:broader nalt:1019 ;
  skos:definition nalt:10543_def ;
  skos:exactMatch agrovoc:c_29626, <http://id.cabi.org/cabt/60615>, <http://id.agrisemantics.org/gacs/C10748>, <http://id.loc.gov/authorities/subjects/sh85064592> ;
  skos:inScheme <https://lod.nal.usda.gov/nalt>, <https://lod.nal.usda.gov/nalt-core> ;
  skos:narrower nalt:3926 ;
  skos:prefLabel "immunotherapy"@en, "inmunoterapia"@es ;
  skos:related nalt:10225, nalt:335656, nalt:46965 ;
  ns0:marc001 "19263" .

nalt:10225
  a ns0:Topic, skos:Concept ;
  skos:prefLabel "antisuero"@es, "antiserum"@en ;
  skos:related nalt:10543 .

nalt:335656
  a ns0:Topic, skos:Concept ;
  skos:prefLabel "alergoides"@es, "allergoids"@en ;
  skos:related nalt:10543 .

nalt:46965
  a ns0:Topic, skos:Concept ;
  skos:prefLabel "inmunosupresión"@es, "immunosuppression"@en ;
  skos:related nalt:10543 .

nalt:3926
  a ns0:Topic, skos:Concept ;
  skos:broader nalt:10543 ;
  skos:prefLabel "inmunización"@es, "immunization"@en .

nalt:1019
  a ns0:Topic, skos:Concept ;
  skos:narrower nalt:10543 ;
  skos:prefLabel "terapéutica"@es, "therapeutics"@en .